TRAVERE THERAPEUTICS INC. - COMMON STOCK
17.44
26-أغسطس-25 13:45:00
15 متأخرة بدقائق
الأسهم
+0.21
+1.22%
نطاق اليوم
17.13 - 17.54
ISIN
N/A
المصدر
NASDAQ
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 مارس 2022 14:00:00 بحسب Nasdaq GlobeNewswire
-
Travere Prices Upsized $275 Million Convertible Senior Notes Offering
08 مارس 2022 18:00:26 بحسب Nasdaq GlobeNewswire
-
Travere Announces Proposed Convertible Senior Notes Offering
08 مارس 2022 04:00:01 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the Barclays Global Healthcare Conference
03 مارس 2022 13:30:00 بحسب Nasdaq GlobeNewswire
-
28 فبراير 2022 05:00:02 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
24 فبراير 2022 13:01:01 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 فبراير 2022 14:00:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results
10 فبراير 2022 13:30:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
09 فبراير 2022 13:30:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 يناير 2022 14:00:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Provides Corporate Update and 2022 Outlook
10 يناير 2022 04:00:02 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Appoints Jula Inrig, M.D., as Chief Medical Officer
04 يناير 2022 13:30:00 بحسب Nasdaq GlobeNewswire
-
15 ديسمبر 2021 04:00:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 ديسمبر 2021 13:30:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at Upcoming Investor Conferences
11 نوفمبر 2021 13:30:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics to Present Abstracts at American Society of Nephrology Kidney Week 2021
02 نوفمبر 2021 13:30:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Third Quarter 2021 Financial Results and Organizational Progress
28 أكتوبر 2021 13:01:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics to Report Third Quarter 2021 Financial Results
14 أكتوبر 2021 13:30:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 أكتوبر 2021 14:00:00 بحسب Nasdaq GlobeNewswire
-
Travere Therapeutics Announces Transition of Chief Medical Officer
12 أكتوبر 2021 14:00:00 بحسب Nasdaq GlobeNewswire